Scrip
Genzyme discontinues follow-on to Renvela
20 November 2009
Malini Guha
Please Login to read the full article.
20 November 2009
Malini Guha
Genzyme has discontinued development of the potential follow-on to its drug Renvela (sevelamer carbonate), as the advanced phosphate binder (APB) did not show a significant improvement in phosphate lowering compared with Renvela in a Phase II/III trial in adult haemodialysis patients with hyperphosphataemia.
Genzyme...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face-to-face: EyeGate looks beyond iontophoresis dry eye trial
- Face-to-Face: Trophos looks to nourish ALS market with olesoxime
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
